POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 1 filers reported holding POSEIDA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,030 | +35.4% | 7,608 | 0.0% | 0.00% | +50.0% |
| Q2 2023 | $13,313 | -43.0% | 7,608 | 0.0% | 0.00% | -50.0% |
| Q1 2023 | $23,355 | -42.1% | 7,608 | 0.0% | 0.00% | -50.0% |
| Q4 2022 | $40,321 | +49.3% | 7,608 | 0.0% | 0.01% | +33.3% |
| Q3 2022 | $27,000 | +35.0% | 7,608 | 0.0% | 0.01% | +50.0% |
| Q2 2022 | $20,000 | -41.2% | 7,608 | 0.0% | 0.00% | -20.0% |
| Q1 2022 | $34,000 | -34.6% | 7,608 | 0.0% | 0.01% | -37.5% |
| Q4 2021 | $52,000 | +1633.3% | 7,608 | +1579.5% | 0.01% | – |
| Q3 2021 | $3,000 | -40.0% | 453 | 0.0% | 0.00% | -100.0% |
| Q2 2021 | $5,000 | +25.0% | 453 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $4,000 | – | 453 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,043,267 | $7,605,000 | 1.52% |
| Privium Fund Management (UK) Ltd | 48,470 | $353,000 | 0.38% |
| Pentwater Capital Management LP | 4,967,227 | $36,211,000 | 0.37% |
| J. Goldman & Co LP | 301,391 | $2,197,000 | 0.11% |
| Perceptive Advisors | 787,745 | $5,743,000 | 0.08% |
| KNOTT DAVID M | 29,566 | $216,000 | 0.08% |
| Virtus ETF Advisers LLC | 23,082 | $168,000 | 0.07% |
| Altium Capital Management LP | 32,238 | $235,000 | 0.06% |
| Advisory Services Network, LLC | 268,290 | $1,956,000 | 0.06% |
| MCF Advisors LLC | 66,185 | $482,000 | 0.05% |